1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
622A9104C89213F590025884B003E12C7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-optimizing-competitive-intelligence-function-operating-model-roles-reporting?OpenDocument
18
19OpenDocument
203.223.3.251
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Structure and Alignment

Optimizing the Competitive Intelligence Function: Operating Model, Roles, and Reporting

ID: 5724


Features:

12 Info Graphics

10 Data Graphics

140+ Metrics

8 Narratives


Pages/Slides: 29


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Optimizing the Competitive Intelligence Function: Operating Model, Roles, and Reporting”

STUDY OVERVIEW

A robust Competitive Intelligence function helps set the strategic direction of an organization in the complex and ever-changing pharmaceutical marketplace.

Organizations must optimize the structure and capabilities of their Competitive Intelligence function to achieve high impact and mitigate numerous market risks.

Best Practices, LLC undertook this benchmarking research to identify how leading pharmaceutical and biotechnology companies are improving the efficiency and effectiveness of their Competitive Intelligence function. In particular, this study delivers benchmarks and insights around current approaches to the operating model, roles and responsibilities of the Competitive Intelligence function.

KEY TOPICS

  • Structures of Competitive Intelligence functions, strengths and weaknesses of different structures, best practices
  • Roles and reporting relationships: Competitive Intelligence stakeholders, reporting roles, reporting functions, geographic span of responsibility

KEY METRICS
  • Operating model of Competitive Intelligence function - Large companies vs. Small-mid sized companies
  • Evolution of Competitive Intelligence structures over time
  • Functional leadership of the Competitive Intelligence function
  • Competitive Intelligence ultimate reporting level
  • Functional area of the person to whom the leader (direct manager) of Competitive Intelligence function directly reports - Large companies and small-mid sized companies
  • Key stakeholders for the Competitive Intelligence function

SAMPLE KEY FINDINGS
  • Competitive Intelligence Reporting Roles and Functions: For the large company segment, 76% report to senior director or above. Meanwhile, 50% of small–mid companies report to vice presidents. Typically, Competitive Intelligence sits in the market research/business analytics function (large companies – 58%; small-mid companies – 38%).

METHODOLOGY

Best Practices, LLC engaged 38 Competitive Intelligence leaders from 31 biopharmaceutical companies through a benchmarking survey instrument and focus group interviews. Directors / Heads were the major contributors to this study, followed by Managers.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; Biotech; Manufacturing; Medical Device; Chemical; Consumer Products; Clinical Research; Laboratories; Consulting


Companies Profiled:
Abbott; Alkermes; Alnylam Pharmaceuticals; Amgen; Astellas; AstraZeneca; BioCryst Pharmaceuticals; Biogen; Bioventus; Cerevel Therapeutics; Clovis Oncology; CSL Behring; Daiichi Sankyo; Genentech; Ipsen; Ironwood; Novartis; Novo Nordisk; Orion Pharmaceuticals; Pfizer; Roche; Sanofi; SCIEX; Servier; Shire; Sunovion; Takeda Pharmaceuticals; Tesaro; Teva Pharmaceutical Industries Ltd; UCB Pharma; Uintah Consulting LLC

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.